Telling people to 'just say no' to human interaction won't work. Cities, states & colleges should get creative & invest in safe socializing. usatoday.com/story/opinion/… @usatoday @gregggonsalves
CC: @edyong209 @HelenBranswell @apoorva_nyc since I feel like the 3 of you might enjoy this piece by @gregggonsalves and me.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Josh Barocas, MD

Josh Barocas, MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @jabarocas

10 Sep
It's not #COVID, but our new 🔥 study found that more than 280,000 people in the US who inject drugs will die of endocarditis in the next 10 years (>7.2 million years of potential life lost). @IDSA (thread 1/) academic.oup.com/cid/cid/advanc…
We developed a simulation model of injection drug use to project the long term prevalence of endocarditis, skin infections, and overdose--and interventions that might curb the syndemic (The REDUCE model) @NIDAnews @RWalensky (2/) @CHERISHresearch
We found that by 2030, one-third of the mortality will be due to overdose and 20% will be due to endocarditis. @The_BMC @felicejfreyer (3/)
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!